Skip to content

Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19)

Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029751
Enrollment
Unknown
Registered
2020-02-12
Start date
2020-02-01
Completion date
Unknown
Last updated
2020-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Sponsors

The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with suspected or confirmed NCP (divided into ordinary type and severe type according to their clinical classification); 2. Be between 18-85 years of age; 3. Informed consent and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe primary diseases such as heart, lung, liver, kidney, brain, and hematopoietic system; 2. pregnant or lactating women; 3. Patients with mental illness; 4. Those who are participating in other clinical trials or taking other Chinese herbal medicines.

Design outcomes

Primary

MeasureTime frame
blood routine examination;CRP;PCT;Chest CT;Liver and kidney function;Etiology test;

Secondary

MeasureTime frame
heart function;ECG;Coagulation;

Countries

China

Contacts

Public ContactMao Wei

The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine

maoweilw@163.com+86 0571-87068001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026